Breaking News Instant updates and real-time market news.

BLUE

Bluebird Bio

$178.20

3.45 (1.97%)

09:10
05/17/18
05/17
09:10
05/17/18
09:10

Bluebird Bio to present LentiGlobin data, bb2121 data at conferences

Bluebird Bio announced that data from ongoing LentiGlobin clinical studies in transfusion-dependent beta-thalassemia and severe sickle cell disease will be highlighted in oral presentations at the 23rd Congress of the European Hematology Association. An encore presentation of data from the ongoing Phase 1 study of bb2121 in relapsed/refractory multiple myeloma, to be debuted at the 2018 American Society of Clinical Oncology meeting, will also be presented.

BLUE Bluebird Bio
$178.20

3.45 (1.97%)

03/28/18
03/28/18
NO CHANGE

Bluebird Bio and Celegene to co-develop bb2121 anti-BMCA therapy
Bluebird Bio (BLUE) and Celgene (CELG) announced that the companies have entered into an agreement to co-develop and co-promote bb2121, an investigational anti-B-cell maturation antigen, or BCMA chimeric antigen receptor, or CAR, T cell therapy for the potential treatment of patients with relapsed/refractory multiple myeloma in the United States.The companies originally entered into a broad, global strategic research collaboration in 2013 to discover, develop and commercialize novel therapies in oncology, which included bb2121.
04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Jefferies highlights other gene theraphy players after AveXis takeover
Novartis' (NVS) deal to acquire AveXis (AVXS) for $8.7B should remind investors about the ongoing attractiveness within smid-cap biotech, Jefferies analyst Michael Yee tells investors in a research note. Novartis' two large gene therapy deals in four months will lead to a question of "who's next," the analyst adds. Yee says other mid-late stage gene therapy players include Bluebird Bio (BLUE), Spark Therapeutics (ONCE), BioMarin (BMRN), Abeona Therapeutics (ABEO), Regenxbio (RGNX), Nightstar Therapeutics (NITE) and Voyager Therapeutics (VYGR).
04/19/18
RHCO
04/19/18
NO CHANGE
Target $232
RHCO
Buy
Bluebird Bio price target raised to $232 from $223 at SunTrust
SunTrust analyst Edward Nash raised his price target on Bluebird Bio to $232 after yesterday's NEJM publication of interim data from the HGB-204 and HGB-205 studies supporting his belief that "all patients in the HGB-207 study have the potential to achieve transfusion independence". The analyst adds that based on the publication, he has "dialed up his eligible beta-thalassemia patient numbers for LentiGlobil" given the prevalence of beta-thalassemia in the U.S. and E.U. of 15,000 cases, yielding an estimate of addressable market at 7,875 vs. his prior view of 2,650. Nash keeps his Buy rating on Bluebird Bio.
05/07/18
BERN
05/07/18
NO CHANGE
Target $194
BERN
Market Perform
Bluebird Bio price target lowered to $194 from $211 at Bernstein
Bernstein analyst Vincent Chen lowered his price target for Bluebird Bio to $194 from $211 to reflect increasing operating expenses. The analyst reiterates a Market Perform rating on the shares.

TODAY'S FREE FLY STORIES

ROL

Rollins

$62.46

0.74 (1.20%)

, ANDV

Andeavor

$157.60

-1.41 (-0.89%)

18:30
09/25/18
09/25
18:30
09/25/18
18:30
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

ROL

Rollins

$62.46

0.74 (1.20%)

ANDV

Andeavor

$157.60

-1.41 (-0.89%)

INGN

Inogen

$258.49

5.5 (2.17%)

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

MPC

Marathon Petroleum

$85.04

-0.78 (-0.91%)

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

  • 19

    Oct

  • 27

    Nov

TJX

TJX

$110.33

0.605 (0.55%)

18:27
09/25/18
09/25
18:27
09/25/18
18:27
Initiation
TJX initiated  »

TJX initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.41

-0.08 (-2.29%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Hot Stocks
Breaking Hot Stocks news story on Community Health »

Community Health up 3.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$47.69

-0.01 (-0.02%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Conference/Events
Aflac to hold financial analysts briefing »

Financial Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TPC

Tutor Perini

$19.55

-0.275 (-1.39%)

18:12
09/25/18
09/25
18:12
09/25/18
18:12
Hot Stocks
Tutor Perini awarded $82M aircraft maintenance contract »

Tutor Perin announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLTH

Nobilis Health

$0.95

-0.0494 (-4.94%)

18:01
09/25/18
09/25
18:01
09/25/18
18:01
Hot Stocks
Nobilis Health names Kenny Klein new CFO »

Nobilis Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:57
09/25/18
09/25
17:57
09/25/18
17:57
Syndicate
FlexShopper 10M share Secondary priced at $1.00 »

Credit Suisse acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:55
09/25/18
09/25
17:55
09/25/18
17:55
Syndicate
FlexShopper 10M unit Secondary priced at $1.00 »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:48
09/25/18
09/25
17:48
09/25/18
17:48
Hot Stocks
Nike says Jordan brand 'incredibly strong' in China »

Says relationship with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:45
09/25/18
09/25
17:45
09/25/18
17:45
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says recent ad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CYH

Community Health

$3.41

-0.08 (-2.29%)

17:43
09/25/18
09/25
17:43
09/25/18
17:43
Hot Stocks
Community Health reaches settlement pact with DOJ over HMA probe »

Community Health Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike sees FY19 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Earnings
Nike sees 'strong' sequential revenue growth in Q2 »

Sees Q2 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

17:38
09/25/18
09/25
17:38
09/25/18
17:38
Hot Stocks
KB Home CEO sees slower sales in higher priced homes »

Comments from Q3 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MTBC

Medical Transcription Billing

$4.96

0.2 (4.20%)

17:36
09/25/18
09/25
17:36
09/25/18
17:36
Syndicate
Breaking Syndicate news story on Medical Transcription Billing »

Medical Transcription…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:34
09/25/18
09/25
17:34
09/25/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says has seen 17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GTX

Garrett Motion

$0.00

(0.00%)

, ACET

Aceto

$2.83

-0.09 (-3.08%)

17:30
09/25/18
09/25
17:30
09/25/18
17:30
Hot Stocks
Garrett Motion to replace Aceto in S&P 600 at open on October 2 »

Honeywell (HON) is…

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

NKE

Nike

$84.79

0.52 (0.62%)

17:27
09/25/18
09/25
17:27
09/25/18
17:27
Hot Stocks
Nike says has returned to 'strong, sustainable growth' in North America »

Says facets of live story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RBNC

Reliant Bancorp

$25.91

-0.27 (-1.03%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Reliant Bancorp raises quarterly cash dividend 33% from last year »

Reliant Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

, INGN

Inogen

$258.49

5.5 (2.17%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Vanda Pharmaceuticals, Inogen »

Vanda Pharmaceuticals to…

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

INGN

Inogen

$258.49

5.5 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 09

    Oct

  • 27

    Nov

INGN

Inogen

$258.49

5.5 (2.17%)

, ROL

Rollins

$62.46

0.74 (1.20%)

17:23
09/25/18
09/25
17:23
09/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Inogen, Rollins »

Inogen to replace Rollins…

INGN

Inogen

$258.49

5.5 (2.17%)

ROL

Rollins

$62.46

0.74 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 09

    Oct

  • 27

    Nov

KBH

KB Home

$25.29

-0.24 (-0.94%)

17:20
09/25/18
09/25
17:20
09/25/18
17:20
Hot Stocks
KB Home sees FY18 housing revenue of $4.6B, low end of prior $4.6B-$4.8B view »

Sees FY18 gross margin of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ROL

Rollins

$62.46

0.74 (1.20%)

, ANDV

Andeavor

$157.60

-1.41 (-0.89%)

17:18
09/25/18
09/25
17:18
09/25/18
17:18
Hot Stocks
Rollins to replace Andeavor in S&P 500 at open on October 1 »

S&P 500 constituent…

ROL

Rollins

$62.46

0.74 (1.20%)

ANDV

Andeavor

$157.60

-1.41 (-0.89%)

MPC

Marathon Petroleum

$85.04

-0.78 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:15
09/25/18
09/25
17:15
09/25/18
17:15
Hot Stocks
Nike says apparel saw 11% growth in Q1 »

Says apparel saw 11%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:15
09/25/18
09/25
17:15
09/25/18
17:15
Hot Stocks
Nike says apparel saw 11% growth in Q1 »

Says apparel saw 11%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.